Singapore optical lens manufacturer MetaOptics (MOT.US) IPO priced at 5-7 USD/ADS, fundraising scale reduced by 45% to 18 million USD.
MetaOptics currently plans to issue 3 million American Depositary Shares (ADS) at a price of $5 to $7 per ADS, raising $18 million.
Singaporean optical lens manufacturer MetaOptics on Wednesday lowered the size of its upcoming initial public offering (IPO). The company now plans to issue 3 million American depositary shares (ADS) at a price of $5 to $7 per ADS, raising $18 million. Previously, the company had planned to issue 4 million ADS at $8.15 per ADS. Based on the midpoint of the new offering price range, the company's fundraising size will decrease by 45% compared to the previous plan. The company plans to list on Nasdaq under the stock symbol "MOT".
Founded in 2021, MetaOptics focuses on researching and manufacturing metalenses, which are ultra-thin flat optical lenses. Compared to traditional curved lenses, metalenses are smaller in size, lighter in weight, and more energy-efficient. The company covers the entire industry chain, including equipment development, wafer foundry production, and end product manufacturing. Additionally, the company integrates artificial intelligence (AI) technology into lens design and image processing processes to enhance imaging resolution, correct optical defects, and optimize computational photography images. In addition to producing metalenses and related prototype products, the company also develops demonstrative and commercialized application products, such as camera modules, infrared cameras, micro projectors, and other Internet of Things (IoT) imaging devices to showcase and promote its technological applications. Data shows that the company achieved $1 million in revenue in the 12 months ending on December 31, 2025.
Related Articles

Jiangsu Hengrui Pharmaceuticals (01276) spent 7.0335 million yuan to repurchase 150,000 A shares on June 11th.

More than 400 million dollars! South Korea imposes the largest fine for data breach on e-commerce giant Coupang (CPNG.US)

Goldman Sachs: Meituan-W (03690) takeaway business profits are recovering, or may achieve breakeven earlier than the next quarter.
Jiangsu Hengrui Pharmaceuticals (01276) spent 7.0335 million yuan to repurchase 150,000 A shares on June 11th.

More than 400 million dollars! South Korea imposes the largest fine for data breach on e-commerce giant Coupang (CPNG.US)

Goldman Sachs: Meituan-W (03690) takeaway business profits are recovering, or may achieve breakeven earlier than the next quarter.

RECOMMEND





